Benefits
Herpes simplex virus (HSV) suppression
The most clinically validated application of lysine: multiple clinical studies and meta-analyses confirm lysine supplementation (1,000–3,000 mg/day) significantly reduces the frequency, duration, and severity of herpes labialis (cold sores) and genital herpes outbreaks. Lysine competes with arginine for absorption and viral replication, as HSV requires arginine for DNA replication and capsid assembly.
Collagen synthesis and bone health
Lysine is essential for collagen synthesis — it is hydroxylated by lysyl hydroxylase to form hydroxylysine, which is required for collagen crosslinking and structural integrity. Adequate lysine supports bone mineralization, wound healing, skin elasticity, and connective tissue repair. Lysine also enhances intestinal calcium absorption.
Carnitine synthesis
Lysine (along with methionine) provides the carbon backbone for endogenous carnitine synthesis. Adequate lysine intake supports the body's ability to produce carnitine for mitochondrial fatty acid transport — making lysine indirectly important for energy metabolism, particularly in populations with low red meat intake.
Anxiety reduction
Clinical studies show lysine supplementation (2.6 g/day) significantly reduces anxiety scores and cortisol levels in stressed individuals — particularly those consuming low-lysine diets. The proposed mechanism involves serotonin receptor modulation (partial antagonism at 5-HT4 receptors) and regulation of stress-induced cortisol secretion.
Mechanism of action
Arginine competition and antiviral activity
Lysine and arginine compete for the same intestinal transporters (CAT-1, CAT-2) and cellular uptake pathways. High lysine concentrations outcompete arginine for absorption, reducing intracellular arginine availability. Since HSV requires arginine for DNA replication, capsid protein synthesis, and viral assembly, lysine supplementation starves the virus of its required substrate while maintaining normal host cell function.
Collagen crosslinking via hydroxylysine formation
Lysyl hydroxylase (LH1-3) hydroxylates specific lysine residues in procollagen chains to form hydroxylysine — a modification required for collagen fiber crosslinking via lysyl oxidase. Without adequate hydroxylysine formation, collagen fibers cannot form the stable intermolecular crosslinks needed for tensile strength in bone, tendons, and skin.
5-HT4 receptor partial agonism for anxiety modulation
Lysine acts as a partial agonist/antagonist at serotonin 5-HT4 receptors in the gut-brain axis, modulating serotonin signaling pathways involved in anxiety and stress responses. This mechanism explains the cortisol-reducing and anxiolytic effects observed in clinical studies with lysine supplementation in stressed populations.
Clinical trials
Multiple older randomized trials and observational studies examining L-lysine (typically 1-3 g/day) for prevention/treatment of recurrent oral herpes (HSV-1) and genital herpes (HSV-2). Mechanism: lysine competes with arginine (which HSV requires for replication); lysine-to-arginine dietary ratio matters. (Griffith et al. 1987 and earlier 1980s trials)
Pooled across older HSV trials.
Lysine modestly reduced recurrence rates and severity of HSV outbreaks in some trials, with mixed results across studies. CRITICAL CONTEXT: most of the supportive evidence is older (1980s); modern HSV management uses antivirals (acyclovir, valacyclovir, famciclovir — much more effective than lysine for severe/frequent recurrences). Lysine may have niche role for mild/infrequent outbreaks or as adjunct to suppressive antivirals. Modern Cochrane-style review of lysine for HSV would likely show modest effects with low-quality evidence base.
Randomized, double-blind, placebo-controlled trial of L-lysine (2.64 g/day) + L-arginine (2.64 g/day) vs placebo in 108 healthy adults under stress. Outcomes: STAI anxiety scores, salivary cortisol response. (Smriga et al. 2007, Biomed Res)
108 healthy adults.
Lysine + arginine combination reduced state anxiety scores (STAI) and salivary cortisol stress response vs placebo. Mechanism speculative — possibly involving glutamatergic and HPA axis effects. Note: small effect size; not established anxiolytic; benzodiazepines and SSRIs remain first-line for clinical anxiety.